Observation on the Effect of Combination of Budesonide and Compound Ipratropium Bromide in the Clinical Treatment of Children with Bacterial Bronchopneumonia
Objective To investigate the clinical effect of budesonide and compound ipratropium bromide in the treatment on children with bacterial bronchopneumonia.Methods A total of 80 children with bacterial bronchopneumonia admitted to our hospital from January to December 2023 were selected as the study objects, and were divided into a control group and an observation group according to random number table method, with 40 cases in each group.The control group received conventional treatment, the observation group received budesonide and compound ipratropium bromide combined treatment.The clinical efficacy, inflammation index level, symptom improvement time, hospital stay and adverse reactions were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group, the difference was statistically significant (P<0.05).After treatment, the white blood cell count, neutrophil percentage and C-reactive protein levels in the two groups were lower than before treatment, and the observation group was lower than the control group, the differences between the groups were statistically significant (P<0.05).The symptom improvement time and hospitalization time in the observation group were shorter than those in the control group, and the differences between the groups were statistically significant (P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion The combination of budesonide and compound ipratropium bromide in the treatment of children with bacterial bronchophenitis has a good effect, can effectively reduce the level of inflammation indicators, is conducive to shortening symptoms and hospital stay, and promote the recovery of children, and has good safety.
NETL
NSTL
万方数据
